Displaying drugs 2701 - 2725 of 3953 in total
Taniraleucel
Investigational
Matched Synonyms: … Allogeneic natural killer (NK) cells derived from CD34+ human placental stem/progenitor cells. …
Lixmabegagene relduparvovec
Lixmabegagene relduparvovec, formerly known as LYS-GM101, is a recombinant adeno-associated virus vector serotype rh.10 (AAVrh.10) carrying the human β-galactosidase gene (GBL1). It is under development for the treatment of GM1 gangliosidosis.
Experimental
Matched Description: … serotype rh.10 (AAVrh.10) carrying the human β-galactosidase gene (GBL1). ... Lixmabegagene relduparvovec, formerly known as LYS-GM101, is a recombinant adeno-associated virus vector …
Iodine I-131 monoclonal antibody 81C6
Neuradiab is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).
Investigational
Matched Synonyms: … Moab, 81c6, murine, iodine-I-131 radiolabeled, to human glioma …
AT-GTX-502
AT-GTX-502 is an experimental, one-time gene therapy that uses AAV9 to deliver a functional copy of CLN3.
Investigational
Matched Categories: … Non-Replicating Recombinant, Self-Complementary Adeno-Associated Virus Serotype 9 Containing the Human …
Briakinumab
Briakinumab is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of T-cell driven autoimmune diseases. It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation, such as pro-inflammatory interleukins or tumor necrosis factor- alpha. Briakinumab represents a novel approach to treating psoriasis, Multiple...
Investigational
Matched Description: … It targets and neutralize interleukin-12 and interleukin-23, two proteins associated with inflammation ... Briakinumab is a human anti-IL-12 monoclonal antibody being developed for the treatment of a number of …
Matched Categories: … Interleukin Inhibitors …
Matched Categories: … Interleukin Inhibitors …
CDX-1135
CDX-1135, formerly TP-10, is a soluble, recombinant human Complement Receptor Type 1 (sCR1) developed by Avant Immunotherapeutics (now Celldex). It was investigated in clinical trials for post-cardiopulmonary bypass syndrome and kidney damage.
Investigational
Matched Description: … CDX-1135, formerly TP-10, is a soluble, recombinant human Complement Receptor Type 1 (sCR1) developed …
Matched Categories: … Recombinant Proteins …
Matched Categories: … Recombinant Proteins …
Thiocolchicoside
Thiocolchicoside is a semi-synthetic derivative of the colchicine, a natural anti-inflammatory glycoside which originates from the flower seeds of Superba gloriosa. It is a muscle relaxant with anti-inflammatory and analgesic effects. It has potent convulsant activity and should not be administered to individuals prone to seizures.
Experimental
Matched Iupac: … 3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}tricyclo[9.5.0.0²,⁷]hexadeca-1(16),2,4,6,11,14-hexaen-10 …
Matched Mixtures name: … TIYOKSEN 550 MG/8 MG FILM TABLET,10 ADET ... LEODEX PLUS 25 MG/8 MG FILM KAPLI TABLET,10 TABLET ... LEODEX PLUS 50 MG/8 MG FILM KAPLI TABLET,10 TABLET …
Matched Products: … KENFIX 8 MG TABLET, 10 TABLET ... FIXOLINE 8MG KAPSÜL, 10 KAPSÜL ... TIYOZID 8 MG TABLET, 10 ADET …
Matched Mixtures name: … TIYOKSEN 550 MG/8 MG FILM TABLET,10 ADET ... LEODEX PLUS 25 MG/8 MG FILM KAPLI TABLET,10 TABLET ... LEODEX PLUS 50 MG/8 MG FILM KAPLI TABLET,10 TABLET …
Matched Products: … KENFIX 8 MG TABLET, 10 TABLET ... FIXOLINE 8MG KAPSÜL, 10 KAPSÜL ... TIYOZID 8 MG TABLET, 10 ADET …
VPM4001
VPM4001 is an allogeneic vaccine for treatment of prostate carcinoma. It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells.
Investigational
Matched Description: … It consists of irradiated human LNCaP cells that have been genetically modified to permanently secrete ... interferon-γ and interleukin-2 (LNCaP/IL-2/IFN-γ). ... Interferon-γ enhances presentation of tumour antigens, whereas interleukin-2 stimulates T cells. …
MVR-T3011
MVR-T3011 is a genetically modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1 antibody.
Investigational
Matched Description: … interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1 antibody. ... modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human …
Nanrilkefusp alfa
Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
Investigational
Matched Description: … Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity …
EGEN-001
EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin 12 (IL-12) and a biocompatible, biodegradable delivery polymer with potential antineoplastic activity.
Investigational
Matched Description: … EGEN-001 is a novel non-viral vector consisting of a plasmid DNA encoding the human gene for interleukin …
RP-A601
RP-A601 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
Investigational
Matched Description: … RP-A601 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase …
FBX-101
FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
Investigational
Matched Description: … FBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase …
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
Fontolizumab
Fontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.
Investigational
BREN-02
BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1).
Investigational
Matched Description: … BREN-02 is a recombinant human homeoprotein Engrailed 1 (rhEN1). …
ACT-101
ACT-101 is a recombinant human alpha-fetoprotein or rhAFP.
Investigational
Matched Description: … ACT-101 is a recombinant human alpha-fetoprotein or rhAFP. …
CPGJ602
CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody.
Investigational
Matched Description: … CPGJ602 is a recombinant anti-EGFR human-mouse chimeric monoclonal antibody. …
MANF
MANF is a human recombinant mesencephalic, astrocyte-derived neurotrophic factor.
Investigational
Matched Description: … MANF is a human recombinant mesencephalic, astrocyte-derived neurotrophic factor. …
MDX-018
MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Trials will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD)...
Investigational
Matched Description: … MDX-018, also known as HuMax-Inflam, is a fully human antibody that is directed to IL-8 (interleukin- ... pre-clinical studies, HuMax-Inflam has been shown to inhibit tumor growth in tumor models using primary human …
AVB-101
AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene.
Investigational
Matched Description: … AVB-101 is a recombinant AAV9 vector encoding the human progranulin (PGRN) gene. …
AVI-014
AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF).
Investigational
Matched Description: … AVI-014 is a glycosylated, recombinant human granulocyte colony-stimulating factor (G-CSF). …
rAAV9-hNAGLU
rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase.
Investigational
Matched Description: … rAAV9-hNAGLU consists of a recombinant AAV9 expressing human alpha-N-acetylglucosaminidase. …
Displaying drugs 2701 - 2725 of 3953 in total